Shopping Cart

Remove All

Your shopping cart is currently empty

Proceed to checkout Continue shopping

TD-0212 TFA

Name: TD-0212 TFA
Brand: TargetMol
SKU: T13125L
Rating: 4.5 (1 reviews)

😃Good

Catalog No. T13125LCas No. 1073549-11-7

TD-0212 TFA is an orally active dual pharmacology compound, functioning as an antagonist of the angiotensin II type 1 receptor (AT1) with a pKi of 8.9, and as an inhibitor of neprilysin (NEP) with a pIC50 of 9.2.

TD-0212 TFA

😃Good

Catalog No. T13125LCas No. 1073549-11-7

Pack Size	Price	USA Warehouse	Global Warehouse
25 mg	$2,720	3-6 months	3-6 months
50 mg	$3,780	3-6 months	3-6 months
100 mg	$4,900	3-6 months	3-6 months

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Resource Download

Product Introduction

Bioactivity

Description	TD-0212 TFA is an orally active dual pharmacology compound, functioning as an antagonist of the angiotensin II type 1 receptor (AT1) with a pKi of 8.9, and as an inhibitor of neprilysin (NEP) with a pIC50 of 9.2.
Targets&IC50	NEP:9.2(pIC50), AT1:(pKi)8.9
In vitro	TD-0212 exhibits improved dual AT1/NEP inhibition activity and may present a reduced angioedema risk compared to dual ACE/NEP inhibition.
In vivo	In renin-dependent and non-dependent hypertension models, TD-0212 can lower blood pressure, similar to omapatrilat and the combination of AT1 receptor antagonist and NEP inhibitor.

Chemical Properties

Molecular Weight	641.67
Formula	C₃₀H₃₅F₄N₃O₆S
Cas No.	1073549-11-7
Relative Density.	1.31g/cm3

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 125 mg/mL (194.8 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (5.14 mM), Sonication is recommeded.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	1.5584 mL	7.7922 mL	15.5843 mL	77.9217 mL
5 mM	0.3117 mL	1.5584 mL	3.1169 mL	15.5843 mL
10 mM	0.1558 mL	0.7792 mL	1.5584 mL	7.7922 mL
20 mM	0.0779 mL	0.3896 mL	0.7792 mL	3.8961 mL
50 mM	0.0312 mL	0.1558 mL	0.3117 mL	1.5584 mL
100 mM	0.0156 mL	0.0779 mL	0.1558 mL	0.7792 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH₂O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH₂O TargetMol | reagent

mix well and clarify

For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.

All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc